Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.
High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
Stability of rating scale response category interpretations in neurological disorders.
Prevalence and incidence of Multiple Sclerosis in Campobasso (Molise region chieftown, southern Italy).
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics.
Developmental cuprizone exposure impairs oligodendrocyte lineages differentially in cortical and white matter tissues and suppresses glutamatergic neurogenesis signals and synaptic plasticity in the hippocampal dentate gyrus of rats.
Measuring Water Content using T2 Relaxation at 3T: Phantom Validations and Simulations.
Impact of Melatonin on Motor, Cognitive and Neuroimaging Indices in Patients with Multiple Sclerosis.
Correction: deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.
Acute toxic neuropathy mimicking guillain barre syndrome.
Fatigue induced changes to kinematic and kinetic gait parameters following six minutes of walking in people with multiple sclerosis.
Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.
Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research.
Nitric oxide plays a dual role in the oxidative injury of cultured rat microglia but not astroglia.
T2-relaxometry for myelin water fraction xtraction using wald distribution and extended phase graph.
Epistatic effects on the phenotype of multiple sclerosis.
Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.
Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: A potential link.
New Poteintial Serum Biomarkers in Multiple Sclerosis Identified by Proteomic Strategies.
New tools for studying microglia in the mouse and human CNS.
Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials.
Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
Pages
« first
‹ previous
…
561
562
563
564
565
566
567
568
569
…
next ›
last »